Dr. Ernie Bowling discusses dry eye in the digital age

Article

Ernie Bowling, OD, FAAO, takes a deeper look at how digital devices affect dry eye disease. Read his companion article, Dry eye in the digital age.

Related: Dr. Ernie Bowling: Good news is out there during COVID-19

Recent Videos
Easy Anyama at Vision Expo West 2024
Brianna Rhue, OD, FAAO, FSLS, discusses AI and office technology at Vision Expo West
Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO
Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Related Content
Patient smiling at optometrist and sitting for eye exam Image credit: AdobeStock/TylerOlson

AI-driven ambient listening solution now available for eye care providers

Jordana Joy, Associate Editor
October 8th 2024
Article
Split image of dry eye before and after treatment Image credit: ©Alessandro Grandini - adobe.stock.com

Optometrists, organizations provide insight for State of Dry Eye survey

Jordana Joy, Associate Editor;Jessilin Quint, OD, MBA, MS, FAAO;Grace Koennecke
August 16th 2024
Podcast
woman receives perfluorohexyloctane drops during the Kalahari trial for DED - Image credit: Adobe Stock/©RFBSIP

Long-term use of perfluorohexyloctane safe and effective for treating DED

Lynda Charters
September 27th 2024
Article
Podcast: TearRestore CEO, Ken DauSchmidt, reviews new open-eye warm compress treatment

Podcast: TearRestore CEO, Ken DauSchmidt, reviews new open-eye warm compress treatment

Ken DauSchmidt;Brooke Henson, Editor
September 24th 2021
Podcast
Woman getting IOP assessed by iCare's ST500 tonometer Image credit: iCare

iCare debuts ST500 tonometer featuring a slit lamp-mounted design

Hattie Hayes
September 11th 2024
Article
Black and white FDA sign on wall Image credit: ©maurice norbert - adobe.stock.com

FDA confirms acceptability of remaining Phase 3 pivotal clinical trials for Palatin's PL9643 in DED

David Hutton, Managing Editor, Ophthalmology Times
September 10th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.